Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
November 1, 1985
Recombinant alpha 2 interferon for induction and maintenance of remission in hairy cell leukaemia
G Gastl, W Aulitzky, R Margreiter, et al.
British Journal of Haematology
|
October 1, 1984
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes
G Tricot, R De Bock, A W Dekker, et al.
Leukemia Research
|
January 1, 1985
Cytogenetic and DNA-flow cytometric studies of separated blasts
Z N Berneman, R De Bock, L Van Alsenoy, et al.
Annals of Hematology
|
December 1, 1992
Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity
R de Bock, M de Jonge, M Korthout, et al.
Blood
|
March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group
R Zittoun, U Jehn, D Fière, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
B Löwenberg, R Zittoun, H Kerkhofs, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1986
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial
H Ludwig, A Cortelezzi, W Scheithauer, et al.
Haematology and Blood Transfusion
|
January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group
U Jehn, R Zittoun, S Suciu, et al.
Leukemia
|
November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)
T de Witte, S Suciu, M Peetermans, et al.
Cancer Treatment Reports
|
December 1, 1985
Amsacrine with high-dose cytarabine in acute leukemia
R Zittoun, J Bury, P Stryckmans, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
November 1, 1985
Recombinant alpha 2 interferon for induction and maintenance of remission in hairy cell leukaemia
G Gastl, W Aulitzky, R Margreiter, et al.
British Journal of Haematology
|
October 1, 1984
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes
G Tricot, R De Bock, A W Dekker, et al.
Leukemia Research
|
January 1, 1985
Cytogenetic and DNA-flow cytometric studies of separated blasts
Z N Berneman, R De Bock, L Van Alsenoy, et al.
Annals of Hematology
|
December 1, 1992
Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity
R de Bock, M de Jonge, M Korthout, et al.
Blood
|
March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group
R Zittoun, U Jehn, D Fière, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
B Löwenberg, R Zittoun, H Kerkhofs, et al.
European Journal of Cancer & Clinical Oncology
|
September 1, 1986
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial
H Ludwig, A Cortelezzi, W Scheithauer, et al.
Haematology and Blood Transfusion
|
January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group
U Jehn, R Zittoun, S Suciu, et al.
Leukemia
|
November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)
T de Witte, S Suciu, M Peetermans, et al.
Cancer Treatment Reports
|
December 1, 1985
Amsacrine with high-dose cytarabine in acute leukemia
R Zittoun, J Bury, P Stryckmans, et al.
Page
of 5